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Abstract Heating of the serpin Cl-inhibitor above 55°C in- 
duced the formation of inactive polymers. Western blotting of 
non-denaturing els showed that the polymers bound to the con- 
formation specific monoclonal antibody 4C3, suggesting that a 
similar conformational change to that occurring in complexed or 
cleaved inhibitor had taken place. N-Terminal analysis of tryptic 
peptides which bound to 4C3 showed that the epitope resides 
within residues 288-444, a region which includes parts of E-sheets 
A and C. a~-Antichymotrypsin, aa-antiplasmin, angiotensinogen 
and thyroxine binding globulin also polymerised on heating, indi- 
cating that his is a property of many serpins. 
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I. Introduction 
The serpins are a diverse family of proteins, many of which 
are serine proteinase inhibitors (for example, Cl-inhibitor, an- 
tithrombin, cq-proteinase inhibitor and PAI-1), although some 
have no known inhibitory function (for example, ovalbumin) 
[1]. A characteristic of serpins is that the native molecule is not 
the most stable form but a kinetically trapped metastable inter- 
mediate [2]. Also, the serpin reactive centre loop region which 
binds to the proteinase is able to adopt a variety of conforma- 
tions [3]. One of these conformational states involves the inter- 
action of the reactive centre loop with fl-sheet C of an adjacent 
molecule, which can lead to polymer formation. 
Polymer formation has been implicated in the pathological 
states associated with the ~l-proteinase inhibitor Z, and the 
antithrombin Rouen-VI, variants [4-6]. Variants of Cl-inhibi- 
tor which readily polymerise have also been reported [7,8]. 
Following reaction with target proteinases normal plasma C1- 
inhibitor undergoes a conformational change detected by a 
monoclonal antibody which can bind complexed or reactive 
centre loop cleaved Cl- inhibitor [9,t0]. We report here that 
normal plasma Cl-inhibitor readily polymerises on heating, 
and that these polymers bind to this monoclonal antibody. 
2. Materials and methods 
Cls was from Enzyme Research Laboratories (South Bend, IN) and 
Cl-inhibitor was provided by Dr. E.P. P~ques (Behring, Marburg, 
Germany). Both were assayed asdescribed previously [11]. Cl-inhibitor 
was run over a column of Sepharose-CLGB (Pharmacia, Piscataway, 
NJ) prior to use to remove any polymers which spontaneously form on 
storage. Angiotensinogen, ~2-antiplasmin a d cq-antichymotrypsin 
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were from Athens Research (Athens, GA). Thyroxine binding lobulin 
was from Calbiochem (San Diego, CA). TPCK-treated bovine trypsin 
was from Worthington (Freehold, N J) and was active site-titrated with 
para-nitrophenol guanidinobenzoate [12]. Monoclonal antibodies 3C7 
and 4C3 were prepared as described previously [9]. 
For qualitative comparison of the effect of trypsin on native and 
heated Cl-inhibitor (Fig. 2), the Cl-inhibitor samples (5 pg) were incu- 
bated with trypsin (0.1 ¢tg) in phosphate-buffered saline at 23°C for the 
indicated times, followed by addition of phenyl methyl sulphonyl fluo- 
ride (PMSF) to 0.5 mM and dichloroisocoumarin (DCI) to 0.8 mM and 
SDS-PAGE [13] sample buffer. For 4C3 epitope analysis, native C1- 
inhibitor (0.35 mg) was digested with trypsin (0.07 rag) in 170 pl of 
29 mM Tris-HC1, pH 8.3, 12 mM calcium chloride, for 30 h at 37°C. 
The reaction was stopped with 170 ¢tl of SDS-PAGE sample buffer 
containing 2% (v/v) fl-mercaptoethanol. Peptides capable of binding 
4C3 were detected and analysed as described below. 
Non-denaturing polyacrylamide g l electrophoresis [14] was carried 
out as described in Sigma technical bulletin MKR 137, except modified 
for mini-slab gels. Non-denaturing gels for Coomassie blue staining 
were 0.75 mm thick and poured onto Gelbond-PAG (FMC, Rockland, 
ME) and non-denaturing gels for western blotting were 1.5 mm thick 
(with no Gelbond used). Following transfer, the nitrocellulose m m- 
branes were blocked in 2% (w/v) BSA (Fraction "V, Sigma). Cl-inhibitor 
was detected with rabbit antiserum against Cl-inhibitor (at 1/4000 
dilution) or with monoclonal ntibodies 3C7 and 4C3 (at 1.5 pg/ml), 
and revealed with goat anti-rabbit IgG or goat anti-mouse IgG conju- 
gated to horseradish peroxidase. Total protein staining was with an 
Avidin-Biotin total protein stain kit (Bio-Rad, Richmond, CA). For the 
Western blots involving tryptic peptides of Cl-inhibitor (Table 1), the 
SDS gels were 10-20% (w/v) acrylamide and contained 0.1 mM thiogly- 
colate. The proteins were transferred onto PVDF membranes, which 
were then blocked in 10% (w/v) dried milk/0.1% (v/v) Tween-20. These 
blots were detected using rabbit anti-Cl-inhibitor 4C3, peroxidase 
conjugated second antibody, and detected by the ECL chemilumines- 
cence method (Amersham, Amersham, UK). For sequence analysis 
PVDF membranes were stained with 0.1% (w/v) Amido black/20% (v/v) 
methanol. The stained peptides were cut from the membrane and se- 
quenced by the Department of Medical Biochemistry, University of 
Geneva. 
3. Results and discussion 
3.1. Formation and properties of  Cl-inhibitor polymers 
To determine the effect of heating on the formation of poly- 
meric Cl- inhibitor species, Cl- inhibitor was incubated at 50, 
55, 60 and 65°C, followed by electrophoresis on non-denatur- 
ing gels (Fig. 1). At 50°C Cl- inhibitor was stable for 60 min. 
At 55°C polymers started to appear after 5 min. At 65°C 
polymers were formed after 1 min, with almost no native inhib- 
itor remaining. At the longer incubation times the size of the 
polymers increased. Longer incubations at 38°C showed that 
Cl- inhibitor was stable for at least 6 days, although by 14 days 
Cl- inhibitor was fully polymerised (not shown). Mild denatu- 
ration of Cl- inhibitor by incubation with 0.9 M guanidine at 
38°C induced extensive polymerisation within 24 h (not 
shown), as has also been shown for antithrombin [6]. 
Native Cl- inhibitor showed two bands on the non-denatur- 
ing gels (Fig. 1, lane 1). Control experiments showed that both 
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Fig. 1. Non-denaturing gel electrophoresis (4.5% (w/v) acrylamide) of 
Cl-inhibitor incubated at various temperatures. Cl-inhibitor (lane 1) 
was incubated at 50°C (panel A), 55°C (panel B), 60°C (panel C), or 
65°C (panel D) for 1 min (lane 2), 2 min (lane 3), 5 min (lane 4), 10rain 
(lane 5), 20 rain (lane 6), 30 rain (lane 7) or 60 min (lane 8), followed 
by addition of non-denaturing sample buffer and storage on ice until 
loading on the gel. Each lane contained 5 pg of Cl-inhibitor. 
bands were fully active since an excess of C1 s could completely 
complex Cl-inhibitor when samples were run on SDS-PAGE. 
The presence of disulphide linked dimers was ruled out given 
that Cl-inhibitor runs as one band on non-reduced SDS- 
PAGE. It is not clear if the two bands represent an active dimer 
or whether the bands are monomeric and run differently under 
non-denaturing conditions due to different glycosylation. 
The susceptibility to degradation by trypsin of native and 
polymerised Cl-inhibitor was compared. The primary site of 
cleavage by trypsin in native Cl-inhibitor is the P1-Pa' bond 
which produces amajor fragment of 95,000 Da on non-reduced 
SDS-PAGE [15,16]. On SDS-PAGE both native ~Fig. 2, lane 
1) and heated (Fig. 2, lane 6) Cl-inhibitor un as a monomer 
at 105,000 Da. Under the conditions used for the trypsin diges- 
tion, only a trace amount of the 95,000 Da band was produced 
from native Cl-inhibitor (Fig. 2, lanes 2-5). Under identical 
conditions, the polymerised Cl-inhibitor was extensively de- 
graded to produce a major fragment of 95,000 Da and a minor 
fragment of 67,000 Da (Fig. 2, lanes 7-10). The 95,000 Da 
fragment is likely to be the PrP l '  bond cleaved species. Previ- 
ously, however, it was shown that heated Cl-inhibitor was not 
cleaved by kallikrein [10]. This could be because the optimal 
interaction of kallikrein with Cl-inhibitor requires exosites 
which might be inaccessible or lost in the polymers. Exosites 
involving the P4' residue of PAI-1 have been shown to be essen- 
tial for reaction of t-PA with PAI-1 [17]. If the polymers are 
formed by the insertion of part of the reactive centre loop of 
one molecule into ]Lsheet C of an adjacent molecule, such that 
the reactive centre loop of this second molecule is disrupted and 
can interact with t-sheet C of another and so on [3], then the 
PrP I '  bonds might still be accessible to trypsin, and perhaps 
in a more favourable conformation for cleavage. In addition, 
when Cl-inhibitor is in a large excess over trypsin, such as is 
the case here, a transient inhibition of trypsin can be detected 
by chromogenic substrate assay (Patston, unpublished ata). 
Thus, part of the apparent difference might also reflect that 
polymeric Cl-inhibitor is not able to inhibit trypsin. 
3.2. Immunoreactivity of polymerised Cl-inhibitor 
Monoclonal antibody 4C3 binds to cleaved and complexed 
Cl-inhibitor but not to the native protein [9,10] and is, there- 
fore, an indicator of conformational changes involving the re- 
active centre loop. Thus, it was tested if polyinerisation could 
induce the formation of the epitope. Native, heated and Cls- 
complexed Cl-inhibitor were run on non-denaturing gels, fol- 
lowed by Western blotting with 3C7 and 4C3 (Fig. 3). Mono- 
clonal antibody 3C7 detected all forms of the inhibitor [9] as 
can be seen from panel A, where it bound to the native doublet 
(lane 1), the polymers (lane 2), and the Cls-Cl-inhibitor com- 
plex (lane 3). In contrast, 4C3 bound to the polymeric and 
complexed Cl-inhibitor but not to the native protein, thereby 
confirming that the doublet was native protein, and indicating 
that the polymers had undergone a conformational change 
similar to that occurring on cleavage at P1 or complexation with 
proteinase (panel B). For comparison, the protein stained blot 
is shown in panel C. The lowest molecular weight band seen 
with the heated Cl-inhibitor (lane 2) bound to 4C3, yet ran 
close to the position of native protein. This probably represents 
Table 1 
Trypsin cleavage fragments of Cl-inhibitor and reactivity with 4C3 
Peptide Mr Reactivity N-terminal Probable peptide 
(kDa) with 4C3 amino acid sequence 
80 + Ile-56 Ile-56-Arg-444* 
48.5 + Val- 141 Val- 141 -Arg-444* 
38 - Val-228 Val-228-Ala-478** 
26 + Met-288 Met-288 Arg-444* 
*Arg-444 is the Pt residue. Cleavage t this site induces the formation 
of the 4C3 epitope. 
**Ala-478 is the C-terminal residue. This peptide does not bind to 4C3 
probably because the PI-PI' bond is intact. 
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Fig. 2. Cleavage of native and polymerised Cl-inhibitor by trypsin. Lane 1 = native Cl-inhibitor (5 ¢tg); lanes 2-5 = native Cl-inhibitor was incubated 
with active site titrated trypsin at a 1:50 (w:w) ratio for 1 min (lane 2), 5 min (lane 3), 10 rain (lane 4) or 20 min (lane 5), followed by addition of 
PMSF to 0.5 mM and DCI to 0.8 mM and sample buffer; lane 6 = heated C1 -inhibitor (65°C, 30 rain); lanes 7-10 = heated Cl-inbibitor was incubated 
with active site titrated trypsin at a 1:50 (w:w) ratio for 1 min (lane 7), 5 min (lane 8), 10 min (lane 9) or 20 rain (lane 10) followed by addition of 
PMSF to 0.5 mM and DCI to 0.8 mM and sample buffer. The samples were un on 7.5% (w/v) acrylamide SDS-PAGE. 
a monomeric form in which the reactive centre loop has under- 
gone partial insertion into fl-sheet A with corresponding loss 
offl-sheet 1C, but without interaction with another molecule, 
such as is proposed to occur in the latent form of ~l-proteinase 
inhibitor [18]. 
3.3. Localisation of the epitope for monoclonal antibody 4C3 
The epitope for 4C3 is present on cleaved, complexed and 
polymeric Cl- inhibitor but not the native protein. To localise 
the epitope, native Cl- inhibitor was extensively digested with 
trypsin, and subjected to electrophoresis and Western blotting. 
The peptides which bound to 4C3 and the amino-terminal res- 
idue of these peptides are shown in Table 1. The smallest pep- 
tide reacting with 4C3 was at 26 kDa, and amino-terminal 
sequencing showed that it began at Met-288. Thus, since the 
4C3 epitope is produced as a result of cleavage after Arg-444, 
this localises the epitope to a maximum peptide length of resi- 
dues 288-444, which would be consistent with the size of this 
fragment. This region would contain, in linear order, the sec- 
ondary structure lements helix G, helix H, fl-sheet 2C, fl-sheet 
6A, helix I, fl-sheet 5A, and the reactive center loop (fl-sheet 4A 
in the cleaved molecule) [1]. Previously it was shown that 4C3 
A B C 
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Fig. 3. Western blots of non-denaturing gels (5.5% (w/v) acrylamide) showing presence of the 4C3 epitope on polymerised Cl-inhibitor. 2/.zg native 
Cl-inhibitor (lane 1), 5/zg heated (65°C, 30 min) Cl-inhibitor (lane 2) and 2 pg native Cl-inhibitor incubated with 3 #g Cls for 30 rain (lane 3), 
were run on the non-denaturing gel followed by transfer to nitrocellulose paper. Panel A is Cl-inhibitor detection with monoclonal ntibody 3C7 
(which recognizes all forms of the protein), panel B is detection with monoclonal ntibody 4C3 and panel C is total protein staining. 
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Fig. 4. Polymerisation of other serpins, cq-Antichymotrypsin (lanes 1 
and 2), ~:-antiplasmin (lanes 3 and 4), thyroxine binding lobulin (lanes 
5 and 6) and angiotensinogen (lanes 7 and 8) were run on 6.5% (w/v) 
acrylamide (lanes 1-4) or 7% (w/v) acrylamide (lanes 5 8)non-denatur- 
ing gels without heating (lanes l, 3, 5 and 7) or after heating at 65°C 
for 30 min (lanes 2,4 and 6) or 1 min (lane 8). 10¢tg of protein was run 
in each lane. 
did not bind to a synthetic peptide corresponding to residues 
P19-P4 [19], a region which contains part of the reactive centre 
loop and part of fl-sheet 5A. With this information the 4C3 
epitope can be localised further to residues 288-425. On the 
basis of the data reported here and the evidence supporting the 
reactive centre loop-fl sheet C interaction mechanism of polym- 
erisation [3], it seems feasible that the conformation offl-sheet 
2C is an important determinant of neo-epitope expression. 
3.4. Polymerisation of  other serpins 
Cl-inhibitor, ~l-proteinase inhibitor, antithrombin III and 
PAI-2 all readily polymerise [4~8,20~2]. To test if this is a 
general phenomenon of serpins, the ability of cq-antichymo- 
trypsin, ~2-antiplasmin, thyroxine binding globulin and angio- 
tensinogen to polymerise on heating was tested (Fig. 4). These 
serpins all formed polymers as a result of heating at 65°C. The 
ability of a serpin to polymerise does not correlate with inhib- 
itory activity given that the non-inhibitory thyroxine binding 
globulin, angiotensinogen, and the Cl-inhibitor (Mo) mutant 
[7] all readily polymerise. In contrast, heating or mild denatura- 
tion of the non-inhibitory ovalbumin induces the formation of 
the more stable S-ovalbumin isomer and heating of PAI-1 
causes latent PAI-1 formation ([23,24]; and data not shown). 
S-Ovalbumin is probably formed by partial insertion of resi- 
dues in the P~ region into fl-sheet A [23], whereas latent PAI-1 
is formed by complete insertion of the reactive centre into 
fl-sheet A [25]. Why these serpins do not form polymers is not 
clear. 
3.5. Conclusions 
In this study we have shown that normal plasma C 1-inhibitor 
forms polymers on heating or mild denaturation. This results 
in the appearance ofa neo-epitope which is probably associated 
with fl-sheet C. Although the mechanism remains speculative 
polymer formation is a common feature of most serpins, and 
can be added to biosynthesis, ecretion, ligand binding and 
latent state formation as another mechanism by which serpin 
activity, and therefore xtracellular proteolytic pathways, can 
be regulated. In addition, polymer formation is often associated 
with dysfunctional serpins and is clearly indicated in the patho- 
genesis of disease [4-71. 
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